Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

In-Hospital STEMI Patients Face Reperfusion Delays and Worse Outcomes

News Daily News

In-Hospital STEMI Patients Face Reperfusion Delays and Worse Outcomes

Michael O'Riordan

February 06, 2026

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

News Daily News

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

Michael O'Riordan

December 11, 2025

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

News Daily News

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

March 03, 2025

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

Aspirin Should Play Limited Role in Primary Prevention: Review

News Daily News

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Conference News TCT 2016

TRANSFORM-OCT: 生物可吸收和耐久聚合物 DES 早期和晚期愈合率类似

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Curación Precoz y Tardía con SLF Bioreabsorbibles y de Polímero Duradero

Michael O'Riordan

November 02, 2016

News Daily News

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

Michael O'Riordan

July 27, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.